Opioid Use Disorder and Harm Reduction in the Era of Poly-Substance Use-View Presentation Slides

View Presentation Slides

Pdf Summary

In this document from the 2024 American Psychiatric Association, Dr. Kristine Torres-Lockhart discusses the treatment of opioid use disorder with a focus on harm reduction strategies in the context of polysubstance use. The document highlights the importance of patient-centered language to reduce stigma in addiction treatment. Harm reduction practices such as opioid overdose prevention, safer injection practices, and drug testing are emphasized. The use of naloxone for overdose prevention and training laypersons in its administration is also promoted.<br /><br />The agenda covers topics such as the current overdose crisis, evidence-based treatment for opioid use disorder using medications like buprenorphine and methadone, and addressing concomitant stimulant use in opioid use disorder treatment. Different initiation strategies for buprenorphine, including standard, low-dose, and high-dose approaches, are discussed, along with the benefits of long-acting injectable formulations.<br /><br />The document emphasizes the need for comprehensive care to address the rising rates of fatal overdoses, especially in the context of a toxic drug supply and increasing stimulant use. Strategies for harm reduction, evidence-based treatment, and addressing stimulant use disorders are recommended. The importance of utilizing the Opioid Response Network for education, training, and consultation in managing opioid and stimulant use disorders is also highlighted.

Keywords

American Psychiatric Association

Dr. Kristine Torres-Lockhart

opioid use disorder

harm reduction strategies

polysubstance use

patient-centered language

naloxone

overdose prevention

buprenorphine

methadone